Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification

Figure 6

The prediction of SLC24A3 for response to chemotherapeutic agents and immune checkpoint inhibitors. (a) The association between risk score and drug sensitivity estimated by the Spearman analysis. (b) Signaling pathways targeted by drugs that are sensitive (blue) or resistant (red) to the risk score. (c–e) The correlation between SLC24A3 expression and drug sensitivity in CESC. (f, g) Box plots showed differences in TMB (f) and IPS (g) between the SLC24A3 mutation (red) and nonmutation (blue) groups in the TCGA-CESC cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)